Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06783101 · ClinicalTrials.gov registry record · NA
Using a Smart Inhaler to Support Asthma Management in Adolescents With Intellectual and Developmental Disabilities
A NA study of Asthma in Children and Autism Spectrum Disorder (ASD), sponsored by Children's Hospital Los Angeles.
- Recruiting
- Registry status
- NA
- Development phase
- 30
- Enrollment target
- 1
- Study location
NCT06783101: Recruiting NA study of Asthma in Children and Autism Spectrum Disorder (ASD), sponsored by Children's Hospital Los Angeles.
NCT06783101 is a NA study of Asthma in Children and Autism Spectrum Disorder (ASD) that is actively recruiting participants, run by Children's Hospital Los Angeles. The registered enrollment target is 30 participants, below the 204-participant average among 44 other Asthma in Children trials with a reported enrollment target (85% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06783101, a NA study of Asthma in Children and Autism Spectrum Disorder (ASD), is actively recruiting participants, sponsored by Children's Hospital Los Angeles.
- RECRUITING
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
- 1
- Study location
Study Summary
Correct use of daily medications containing inhaled corticosteroids is key for asthma control, yet children with intellectual and developmental disabilities (IDD) face additional barriers to proper inhaler use. Smart inhalers, a novel technology that provides guidance and immediate feedback on inhaler use techniques, have been shown to enhance correct medication administration in the typically developing pediatric population, but their effectiveness has not been evaluated on the pediatric IDD population. This study aims to investigate whether daily application of smart inhalers (1) is feasible and acceptable in the IDD population, (2) improves the rate of correct medication administration, and (3) results in improvement in lung function. This effort aims to promote better asthma management in the IDD population.
Primary Outcome
Feasibility will be determined by data completeness: Ratio of days on which there are valid smart inhaler data out of the total number of days
Conditions Studied
Interventions
- BEHAVIORAL Use of smart inhaler to enhance asthma inhaler proficiency
Study Locations (1)
California
- Children's Hospital Los Angeles - Los Angeles
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2024-08-13 |
| Est. Completion | 2025-04 |
| Phase | NA |
What NCT06783101 shows while recruiting
NCT06783101 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 204-participant average among 44 other Asthma in Children trials with a reported enrollment target (85% lower).
The record links to 4 conditions, with Asthma in Children appearing as the primary indexed condition, and to 1 intervention - of which Use of smart inhaler to enhance asthma inhaler proficiency is the first listed.
NCT06783101 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT06783101 about?
NCT06783101 is a clinical study titled "Using a Smart Inhaler to Support Asthma Management in Adolescents With Intellectual and Developmental Disabilities". Correct use of daily medications containing inhaled corticosteroids is key for asthma control, yet children with intellectual and developmental disabilities (IDD) face additional barriers to proper inhaler use. Smart inhalers, a novel technology that provides guidance and immediate feedback on inhal...
What is the current status of trial NCT06783101?
This trial is currently recruiting. It is a NA study. The enrollment target is 30 participants. The study started on 2024-08-13. Estimated completion is 2025-04.
What conditions does trial NCT06783101 study?
This clinical trial studies the following conditions: Asthma in Children, Autism Spectrum Disorder (ASD), Developmental Disability, Intellectual Disabilities (F70-F79).
What interventions are being tested in trial NCT06783101?
The interventions under investigation include: Use of smart inhaler to enhance asthma inhaler proficiency (BEHAVIORAL).
Who is sponsoring clinical trial NCT06783101?
This trial is sponsored by Children's Hospital Los Angeles, which has 119 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06783101 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Asthma in Children
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06783101's enrollment target sits among peer trials
30 36th of 44 higher than 9 of 44 other Asthma in Children trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Asthma in Children trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Action Towards Health Equity and Improved Air Quality in the Duwamish Valley: A Multilevel Asthma Intervention
RECRUITING · NA
-
SMART Implementation-Effectiveness Trial 1
RECRUITING · NA
-
Mechanistic Study of Inspiratory Training in Childhood Asthma (MICA)
RECRUITING · NA
-
A Culturally Tailored Scalable Asthma Intervention for Hispanic Children (Asthma Guardian)
RECRUITING · NA
-
Impact of Sleep Duration on Immune Balance in Urban Children With Asthma
RECRUITING · NA
-
Reducing Asthma Attacks in Disadvantaged School Children With Asthma
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI